DBV Technologies S.A. (DBVT) Financials
DBVT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 183.0 million | 42.8 million |
2023-09-30 | 189.8 million | 45.8 million |
2023-06-30 | 217.5 million | 53.3 million |
2023-03-31 | 232.9 million | 53.8 million |
DBVT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -14.0 million | 1.2 million |
2023-09-30 | -19.6 million | 1.4 million |
2023-06-30 | -25.7 million | 1.8 million |
2023-03-31 | -21.0 million | 1.6 million |
DBVT Net Income
No data available :(
DBVT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 141.4 million | - | 5.7 million |
2023-09-30 | 149.1 million | - | 1.6 million |
2023-06-30 | 174.0 million | - | 2.1 million |
2023-03-31 | 192.3 million | - | 2.6 million |
DBVT Shares Outstanding
DBVT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 352000 | 28.0 million | 6.4 million | 101000 |
2023-09-30 | 50000 | 13.8 million | 6.2 million | 700000 |
2023-06-30 | 164000 | 17.6 million | 7.0 million | 516000 |
2023-03-31 | 111000 | 16.0 million | 5.2 million | 434000 |
DBVT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | -13.6 million |
2023-09-30 | 2.4 million | 455635 |
2023-06-30 | 2.3 million | 5.0 million |
2023-03-31 | 2.2 million | 3.6 million |
DBVT
Price: $0.67
52 week price:
Earnings Per Share: -0.38 USD
P/E Ratio: -1.56
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 78800
Ebitda: -157.7 millionMarket Capitalization: 138.5 million